Which of the following treatment regimens would not be appropriate for a patient who is consid ered a candidate for bone marrow transplantation?
belongs to book: Hematology Case Review|Donald C. Doll & Radwan F. Khozouz & Wes Matthew Triplett|| Chapter number:64| Question number:4
All Answers
total answers (1)
A. Alkylating agents, such as melphalan, are not recommended in patients who are trans plant -eligible because these agents damage hematopoietic stem cells and interfere with adequate stem cell mobilization.
need an explanation for this answer? contact us directly to get an explanation for this answer